Immunobridging Study: Immunogenicity and Safety of Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine as Heterologue Booster in Adolescent Subjects in Indonesia

Tahapan Penelitian : Complete
Sponsor:
Mitra Pelaksana:
PT Biotis Pharmaceutical Indonesia, Universitas Airlangga
No Registry
INA-6D5D9F9
Tanggal Input Registry : 19-07-2024

01-01-2023
not specified
 
Immunobridging Study: Immunogenicity and Safety of Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine as Heterologue Booster in Adolescent Subjects in Indonesia
Immunobridging Study: Immunogenicity and Safety of Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine as Heterologue Booster in Adolescent Subjects in Indonesia
Interventional
Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) Vaccine
5
 

Inclusion Criteria:

not specified

Exclusion Criteria:

not specified
 
not specified
Not applicable
PPUK/PPUB number
not specified